SCHEMBL26616624

SCHEMBL26616624

C[C@H](NC(=O)CCc1c[nH]c2ccccc12)C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.67
ALDH1A1 P00352 3/20 0.67
KDM4E B2RXH2 2/20 0.67
L3MBTL1 Q9Y468 2/20 0.67
GAA P10253 1/20 0.64
RECQL P46063 3/20 0.58
HPGD P15428 2/20 0.58
HTT P42858 1/20 0.58
POLB P06746 3/20 0.58
APAF1 O14727 1/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2D6 P10635 1/20 0.58
CYP2C19 P33261 1/20 0.58
FAAH O00519 1/20 0.57
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
TDP1 Q9NUW8 2/20 0.56
HCRTR1 O43613 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26616376 1.00 MAPT (0.67) MAPTALDH1A1KDM4EL3MBTL1GAA
SCHEMBL30712556 0.93 KDM4E (0.80) MAPTALDH1A1KDM4EL3MBTL1RECQL
SCHEMBL25609773 0.89 MAPT (0.66) MAPTALDH1A1KDM4EL3MBTL1GAA
SCHEMBL8241650 0.88 ALDH1A1 (0.85) MAPTALDH1A1KDM4EL3MBTL1GAA
SCHEMBL26708909 0.88 MEN1 (0.65) MAPTALDH1A1KDM4EL3MBTL1GAA
SCHEMBL30674423 0.88 MEN1 (0.65) MAPTALDH1A1KDM4EL3MBTL1GAA
SCHEMBL6081797 0.87 KDM4E (0.60) MAPTALDH1A1KDM4EL3MBTL1RECQL
SCHEMBL29394133 0.87 KDM4E (0.60) MAPTALDH1A1KDM4EL3MBTL1RECQL
SCHEMBL468352 0.87 KDM4E (0.60) MAPTALDH1A1KDM4EL3MBTL1RECQL
SCHEMBL7563359 0.86 MAPT (0.70) MAPTALDH1A1KDM4EL3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250288559-A1 PREP BINDING LIGANDS POLKU THERAPEUTICS OY (FI) 2025-09-18 US disclosed
EP-4514781-A1 PREP BINDING LIGANDS Polku Therapeutics OY (FI) 2025-03-05 EP disclosed
CN-119451944-A PREP binding ligands 珀尔库治疗有限公司 2025-02-14 CN disclosed
WO-2023209191-A1 PREP BINDING LIGANDS UNIVERSITY OF HELSINKI (FI) 2023-11-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250288559-A1 PREP BINDING LIGANDS PREP, ERAP2, CTSA MAPT 326/4885ALDH1A1 4707/4885KDM4E 3942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.